These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28885299)

  • 21. Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study.
    Luo Z; Roychoudhury C; Pompos WS; DiMaria J; Robinette CM; Gore PH; Roychoudhury R; Beecroft W
    PLoS One; 2022; 17(12):e0278208. PubMed ID: 36520863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription medication misuse among opioid dependent patients seeking inpatient detoxification.
    Wilens T; Zulauf C; Ryland D; Carrellas N; Catalina-Wellington I
    Am J Addict; 2015 Mar; 24(2):173-177. PubMed ID: 25864607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "It's all connected:" A mixed methods study of insomnia, stigma, and discrimination among individuals on medication for opioid use disorder.
    Nwanaji-Enwerem U; Sadler LS; O'Connell M; Barry D; Knobf TM; Jeon S; Scheinost D; Yaggi K; Redeker NS
    Sleep Health; 2024 Feb; 10(1):31-40. PubMed ID: 37980246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification.
    Bailey GL; Herman DS; Stein MD
    J Subst Abuse Treat; 2013 Sep; 45(3):302-5. PubMed ID: 23786852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study.
    Bearnot B; Mitton JA; Hayden M; Park ER
    J Subst Abuse Treat; 2019 Jul; 102():16-22. PubMed ID: 31202284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
    Kelly MM; Reilly E; Quiñones T; Desai N; Rosenheck R
    Drug Alcohol Depend; 2018 Feb; 183():111-117. PubMed ID: 29245103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceived stigma and its correlates among treatment seeking alcohol and opioid users at a tertiary care centre in India.
    Gyawali S; Sarkar S; Balhara YPS; Kumar S; Patil V; Singh S
    Asian J Psychiatr; 2018 Oct; 37():34-37. PubMed ID: 30103185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.
    Davison JW; Sweeney ML; Bush KR; Davis Correale TM; Calsyn DA; Reoux JP; Sloan KL; Kivlahan DR
    J Addict Dis; 2006; 25(4):27-35. PubMed ID: 17088223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid opioid detoxification.
    Gooberman LL
    JAMA; 1998 Jun; 279(23):1871; author reply 1872. PubMed ID: 9634250
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.
    Subramaniam GA; Stitzer ML; Woody G; Fishman MJ; Kolodner K
    Drug Alcohol Depend; 2009 Jan; 99(1-3):141-9. PubMed ID: 18818027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detoxification treatments for opiate dependent adolescents.
    Minozzi S; Amato L; Davoli M
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006749. PubMed ID: 19370651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
    Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on pharmacotherapy for treatment of opioid use disorder.
    Ayanga D; Shorter D; Kosten TR
    Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra-rapid opioid detoxification: current status and controversies.
    Singh J; Basu D
    J Postgrad Med; 2004; 50(3):227-32. PubMed ID: 15377814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial.
    De Jong CA; Laheij RJ; Krabbe PF
    Addiction; 2005 Feb; 100(2):206-15. PubMed ID: 15679750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internalized stigma and its correlates among treatment seeking opium users in India: A cross-sectional observational study.
    Gupta P; Panda U; Parmar A; Bhad R
    Asian J Psychiatr; 2019 Jan; 39():86-90. PubMed ID: 30594880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
    Stein MD; Kanabar M; Anderson BJ; Lembke A; Bailey GL
    J Subst Abuse Treat; 2016 Sep; 68():57-61. PubMed ID: 27431047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.